Skip to content

Tailored Yoga Therapy for Attention-deficit Hyperactivity Disorder

Tailored Yoga Therapy for Attention-deficit Hyperactivity Disorder in Adults: A Feasibility Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07541820
Acronym
Yoga4ADHD
Enrollment
20
Registered
2026-04-21
Start date
2026-02-23
Completion date
2026-12-31
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit Hyperactivity Disorder, Attention-Deficit Hyperactivity Disorder Symptoms

Keywords

Attention-deficit hyperactivity disorder, Yoga, Therapy, Feasibility, Treatment

Brief summary

This study will explore the feasibility, acceptability, and potential benefits of a group-based tailored yoga programme designed for adults experiencing symptoms of attention-deficit hyperactivity disorder. The yoga intervention will be compared to an active control (group-based functional movement classes).

Detailed description

The primary aim of the study is to test the feasibility and acceptability of a tailored, group-based yoga intervention for adults with attention-deficit hyperactivity disorder, by monitoring recruitment, engagement, and completion rates, and through obtaining qualitative feedback from participants at the end of the intervention. A secondary aim is to explore whether the yoga intervention is associated with improvements in attention-deficit hyperactivity disorder and related symptoms (i.e., anxiety, depression), quality of life, and general functioning, compared to a control intervention (group-based functional movement sessions). The secondary outcomes will be assessed with self-report questionnaires at the start, middle and end of the yoga and control interventions, and three months after completion of the interventions. The investigators will also examine aspects of cognitive and physiological functioning through laboratory testing at the start and end of the intervention, focusing on measures of autonomic activation (e.g., the 'fight or flight response), bodily awareness, attention, and response inhibition. Physiological functioning, such as sleep quality, activity levels, and heart rate, will be monitored throughout the six-week study with wearable devices (e.g., Fitbit activity trackers), to provide longer-term, real-world insights into the possible benefits of the intervention. The investigators will explore whether the yoga intervention is associated with improvements in attention-deficit hyperactivity disorder and related symptoms/abilities, including emotional regulation, social behaviour, attention, focus, interoception and stress reactivity. The investigators will also explore whether the yoga intervention is linked with improved bodily stress markers (heart rate variability), sleep, and physical activity. This feasibility randomised controlled trial will include 20 participants who will be randomly allocated (1:1) to either the group-based tailored yoga therapy intervention (n=10), or a group-based functional movement class (n=10). The latter will be a structured class focusing on light strength, mobility and flexibility. All participants will attend an initial in-person laboratory testing session at the start and end of the 6-week intervention. Each week, both intervention group and control group will attend an in-person one-hour group session. Each week, participants will be asked to practice at least twice, using a 20-minute video recording on demand from home. Outcomes will be measured using self-report, lab-based, and digital wearable measures.

Interventions

BEHAVIORALTailored yoga therapy.

Participants in this arm will participate in a six-week study. They will attend one hour-long group-based in-person session per week, as well as practising from home at least twice weekly following along an online video (which will be a practice of what was learnt in-person that week). Each group yoga session will start with some Pranayama (yogic breathwork) to engage participants' attention and to help them focus. The intervention will progress from purely activating yogic breathwork techniques, to some calming and grounding techniques to aid relaxation, bodily awareness and to reduce stress. Sessions will also involve some faster movements to align the body with typically faster mental activities as seen within individuals with ADHD. Some sessions may progress to include some mindful somatic movements and some longer held poses to enhance relaxation and tension release. Towards the end of the intervention there will be longer opportunities for mindful awareness through meditation.

BEHAVIORALFunctional movement.

Participants in this arm will similarly participate in a six-week study. They will attend one hour-long group-based in-person session per week, as well as practising from home at least twice weekly following along an online video (which will be a practice of what was learnt in-person that week). The functional movement control sessions will serve as an exercise class, with educational aspects. All sessions will follow a similar structure of light strength exercises, mobility exercises and end with some flexibility exercises. This control condition was selected to control for the physical aspects the yoga intervention, allowing us to isolate the possible benefits of yoga due to breathwork and mindfulness.

Sponsors

King's College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Feasibility randomised controlled trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Are aged 18 or older. * Score above the clinical cut-off threshold on the Adult Attention-Deficit Hyperactivity Disorder (ADHD) Self-Report Scale. * Are fluent in English. * Have normal or corrected eyesight.

Exclusion criteria

* Major physical health disorders or disabilities that may affect participation (e.g., uncontrolled epilepsy, significant mobility challenges). * Major mental health disorders that may affect participation (e.g., active psychosis, severe alcohol/substance use disorder). * Current recipient of any other mind-body therapy for attention-deficit hyperactivity disorder. * Current participation in a regular yoga activity. * Current pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility outcomes.From enrolment to the 3-month follow-up.The investigators will monitor recruitment, engagement and completion rates to assess feasibility, and will obtain qualitative participant feedback at the end of the intervention.

Secondary

MeasureTime frameDescription
Exploratory assessment of self-reported change in attention-deficit hyperactivity disorder.From enrolment to the 3-month follow-up.The outcomes will be assessed with self-report questionnaires at the start, middle and end of the yoga and control interventions, and 3-months after completion of the intervention.

Countries

United Kingdom

Contacts

PRINCIPAL_INVESTIGATORSusannah Pick, PhD

King's College London

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026